185 related articles for article (PubMed ID: 34151613)
1. Antisickling effect of chrysin is associated with modulation of oxygenated and deoxygenated haemoglobin via alteration of functional chemistry and metabolic pathways of human sickle erythrocytes.
Nwankwo HC; Idowu AA; Muhammad A; Waziri AD; Abubakar YS; Bashir M; Erukainure OL
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S108-S124. PubMed ID: 34151613
[TBL] [Abstract][Full Text] [Related]
2. Sickling-suppressive effects of chrysin may be associated with sequestration of deoxy-haemoglobin, 2,3-bisphosphoglycerate mutase, alteration of redox homeostasis and functional chemistry of sickle erythrocytes.
Muhammad A; Waziri AD; Forcados GE; Sanusi B; Sani H; Malami I; Abubakar IB; Muhammad A; Muhammad RA; Mohammed HA
Hum Exp Toxicol; 2020 Apr; 39(4):537-546. PubMed ID: 31876182
[TBL] [Abstract][Full Text] [Related]
3. GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease.
Oksenberg D; Dufu K; Patel MP; Chuang C; Li Z; Xu Q; Silva-Garcia A; Zhou C; Hutchaleelaha A; Patskovska L; Patskovsky Y; Almo SC; Sinha U; Metcalf BW; Archer DR
Br J Haematol; 2016 Oct; 175(1):141-53. PubMed ID: 27378309
[TBL] [Abstract][Full Text] [Related]
4. In vitro effects of anthocyanin extracts from Justicia secunda Vahl on the solubility of haemoglobin S and membrane stability of sickle erythrocytes.
Mpiana PT; Ngbolua KN; Bokota MT; Kasonga TK; Atibu EK; Tshibangu DS; Mudogo V
Blood Transfus; 2010 Oct; 8(4):248-54. PubMed ID: 20967165
[TBL] [Abstract][Full Text] [Related]
5. New developments in anti-sickling agents: can drugs directly prevent the polymerization of sickle haemoglobin in vivo?
Oder E; Safo MK; Abdulmalik O; Kato GJ
Br J Haematol; 2016 Oct; 175(1):24-30. PubMed ID: 27605087
[TBL] [Abstract][Full Text] [Related]
6. VZHE-039, a novel antisickling agent that prevents erythrocyte sickling under both hypoxic and anoxic conditions.
Abdulmalik O; Pagare PP; Huang B; Xu GG; Ghatge MS; Xu X; Chen Q; Anabaraonye N; Musayev FN; Omar AM; Venitz J; Zhang Y; Safo MK
Sci Rep; 2020 Nov; 10(1):20277. PubMed ID: 33219275
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, and Biological Evaluation of Ester and Ether Derivatives of Antisickling Agent 5-HMF for the Treatment of Sickle Cell Disease.
Xu GG; Pagare PP; Ghatge MS; Safo RP; Gazi A; Chen Q; David T; Alabbas AB; Musayev FN; Venitz J; Zhang Y; Safo MK; Abdulmalik O
Mol Pharm; 2017 Oct; 14(10):3499-3511. PubMed ID: 28858508
[TBL] [Abstract][Full Text] [Related]
8. Effects of methyl acetyl phosphate, a covalent antisickling agent, on the density profiles of sickle erythrocytes.
Ueno H; Yatco E; Benjamin LJ; Manning JM
J Lab Clin Med; 1992 Jul; 120(1):152-8. PubMed ID: 1613320
[TBL] [Abstract][Full Text] [Related]
9. Effect of piracetam on sickle erythrocytes and sickle hemoglobin.
Asakura T; Ohnishi ST; Adachi K; Ozguc M; Hashimoto K; Devlin MT; Schwartz E
Biochim Biophys Acta; 1981 May; 668(3):397-405. PubMed ID: 7236716
[TBL] [Abstract][Full Text] [Related]
10. Quantitative prediction of erythrocyte sickling for the development of advanced sickle cell therapies.
Lu L; Li Z; Li H; Li X; Vekilov PG; Karniadakis GE
Sci Adv; 2019 Aug; 5(8):eaax3905. PubMed ID: 31457104
[TBL] [Abstract][Full Text] [Related]
11. Sickling-preventive effects of rutin is associated with modulation of deoxygenated haemoglobin, 2,3-bisphosphoglycerate mutase, redox status and alteration of functional chemistry in sickle erythrocytes.
Muhammad A; Waziri AD; Forcados GE; Sanusi B; Sani H; Malami I; Abubakar IB; Oluwatoyin HY; Adinoyi OA; Mohammed HA
Heliyon; 2019 Jun; 5(6):e01905. PubMed ID: 31297461
[TBL] [Abstract][Full Text] [Related]
12. The molecular basis of antisickling agents.
Franklin IM; Huehns ER
Trans R Soc Trop Med Hyg; 1980; 74(6):695-700. PubMed ID: 7210123
[No Abstract] [Full Text] [Related]
13. Interactions of an Anti-Sickling Drug with Hemoglobin in Red Blood Cells from a Patient with Sickle Cell Anemia.
Strader MB; Liang H; Meng F; Harper J; Ostrowski DA; Henry ER; Shet AS; Eaton WA; Thein SL; Alayash AI
Bioconjug Chem; 2019 Mar; 30(3):568-571. PubMed ID: 30794381
[TBL] [Abstract][Full Text] [Related]
14. A Triazole Disulfide Compound Increases the Affinity of Hemoglobin for Oxygen and Reduces the Sickling of Human Sickle Cells.
Nakagawa A; Ferrari M; Schleifer G; Cooper MK; Liu C; Yu B; Berra L; Klings ES; Safo RS; Chen Q; Musayev FN; Safo MK; Abdulmalik O; Bloch DB; Zapol WM
Mol Pharm; 2018 May; 15(5):1954-1963. PubMed ID: 29634905
[TBL] [Abstract][Full Text] [Related]
15. Dimethyl adipimidate: a new antisickling agent.
Lubin BH; Pena V; Mentzer WC; Bymun E; Bradley TB; Packer L
Proc Natl Acad Sci U S A; 1975 Jan; 72(1):43-6. PubMed ID: 1054514
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide reduces sickle hemoglobin polymerization: potential role of nitric oxide-induced charge alteration in depolymerization.
Ikuta T; Thatte HS; Tang JX; Mukerji I; Knee K; Bridges KR; Wang S; Montero-Huerta P; Joshi RM; Head CA
Arch Biochem Biophys; 2011 Jun; 510(1):53-61. PubMed ID: 21457702
[TBL] [Abstract][Full Text] [Related]
17. Ligand kinetics of hemoglobin S containing erythrocytes.
Harrington JP; Elbaum D; Bookchin RM; Wittenberg JB; Nagel RL
Proc Natl Acad Sci U S A; 1977 Jan; 74(1):203-6. PubMed ID: 264675
[TBL] [Abstract][Full Text] [Related]
18. In vitro assessment of the anti-sickling properties of Buchholzia coriacea and Mucuna pruriens seed extracts.
Ikechukwu EL; Okafor PN; Egba SI
In Vitro Cell Dev Biol Anim; 2020 Oct; 56(9):773-782. PubMed ID: 33025340
[TBL] [Abstract][Full Text] [Related]
19. Antisickling effects of 2,3-diphosphoglycerate depletion.
Poillon WN; Kim BC; Labotka RJ; Hicks CU; Kark JA
Blood; 1995 Jun; 85(11):3289-96. PubMed ID: 7756662
[TBL] [Abstract][Full Text] [Related]
20. Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients.
Rab MAE; van Oirschot BA; Bos J; Merkx TH; van Wesel ACW; Abdulmalik O; Safo MK; Versluijs BA; Houwing ME; Cnossen MH; Riedl J; Schutgens REG; Pasterkamp G; Bartels M; van Beers EJ; van Wijk R
Am J Hematol; 2019 May; 94(5):575-584. PubMed ID: 30784099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
